HBIO Total Utang marang Modal Harvard Bioscience, Inc.

HBIO (Harvard Bioscience, Inc.) - tandha merek perusahaan

This daily price chart of the total debt-to-equity ratio for Harvard Bioscience (HBIO) reflects a figure of 6.24 amid spending cuts by biolabs, which is forcing the business to optimize costs. Harvard Bioscience (HBIO) generates revenue through the production of precision instruments, establishing stable component supply channels within the US. High market resilience is based on unique patents and the scientific community's long-standing trust in the brand's equipment.

Rasio Utang marang Ekuitas: harvardbioscience.com (HBIO) kanggo 04.07.2022 - 28.10.2026

Rincian analitis lan laporan data perusahaan harvardbioscience.com (HBIO)

- rega lan prakiraan konsensus rega:
Bagan rega Harvard Bioscience|HBIO - Target konsensus
- data kapitalisasi pasar:
Kapitalisasi pasar Harvard Bioscience|HBIO - Total Nilai Perusahaan
- data kapitalisasi buku:
Nilai Buku saben Saham Harvard Bioscience|HBIO - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku harvardbioscience.com|HBIO - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Harvard Bioscience|HBIO - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Harvard Bioscience, Inc.|HBIO - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Harvard Bioscience|HBIO - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Harvard Bioscience
Ringkesan analisis perusahaan:HBIO, Harvard Bioscience
Produk merek harvardbioscience.com

Harvard Bioscience maintains stability through the deep integration of its precision equipment into global research centers, which minimizes the risk of customer churn. By analyzing the total debt-to-equity ratio, an investor assesses financial leverage and the margin of safety, where an increase in the metric signals over-leverage, while a decrease confirms capital resilience and the fair value of assets.

Analisis perusahaan pesaing

Utang marang Ekuitas ISRG|Rasio Total Utang marang Ekuitas Danaher Corporation|Becton, Dickinson and Company - Total Utang marang Modal|Utang marang Modal STERIS Group (STE)|WST - Total Utang marang Modal|Rasio Utang marang Ekuitas baxter.com BAX|Total Utang marang Modal MASI (Masimo)|STVN - Koefisien Total Utang marang Modal|TFX (Teleflex Inc) - Total Utang marang Modal|Merit Medical Corp (MMSI) - Rasio Total Utang marang Ekuitas|NVST (Envista Holdings) - Total Utang marang Modal|Total Utang marang Modal ICUI|Utang marang Ekuitas Dentsply Sirona (XRAY)|Utang marang Ekuitas LeMaitre Vascular Inc LMAT|Rasio Total Utang marang Ekuitas AtriCure Corp|Rasio Kabeh Utang marang Dana Pribadi STAAR Surgical Co STAA|Total Utang marang Modal NAGE (ChromaDex Corp.)|ZIMV: Koefisien Total Utang marang Modal|Utang marang Ekuitas AngioDynamics|CERS (Cerus Corp.) - Rasio Utang marang Ekuitas|TKNO: Utang marang Ekuitas|Koefisien Total Utang marang Modal Monogram Orthopedics Inc. (MGRM)|Rasio Total Utang marang Ekuitas Sharps Technology, Inc.|Utang Agregat marang Modal INFU (infusystem.com)|Utang marang Ekuitas Utah Medical Products, Inc.|KRMD - Rasio Kabeh Utang marang Dana Pribadi|Nyxoah, S.A. - Rasio Total Utang marang Ekuitas|MBOT: Total Utang marang Modal|PDEX (Pro-Dex, Inc.) - Utang marang Ekuitas|zentek.com (ZTEK) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ELUT (Elutia)|Utang marang Modal MLSS|Utang marang Ekuitas NEXGEL, Inc NXGL|Rasio Utang marang Ekuitas retractable.com RVP|Rasio Total Utang marang Ekuitas Femasys Inc. (FEMY)|Meihua Medical Technologies - Utang Agregat marang Modal|Utang marang Ekuitas POAI (Predictive Oncology Corp)|CJMB - Koefisien Total Utang marang Modal|Total Utang marang Modal Atrion Corp ATRI|NeuroMetrix Corporation (NURO) - Rasio Kabeh Utang marang Dana Pribadi